58
Views
81
CrossRef citations to date
0
Altmetric
Article

Selective Abrogation of BiP/GRP78 Blunts Activation of NF-κB through the ATF6 Branch of the UPR: Involvement of C/EBPβ and mTOR-Dependent Dephosphorylation of Akt

, , , , , , , , & show all
Pages 1710-1718 | Received 12 Aug 2010, Accepted 25 Jan 2011, Published online: 20 Mar 2023

REFERENCES

  • Avruch, J., et al. 2009. Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor. Biochem. Soc. Trans. 37:223–226.
  • Bezy, O., et al. 2005. Delta-interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding protein β, implicated in adipocyte differentiation. J. Biol. Chem. 280:11432–11438.
  • Boyce, M., et al. 2005. A selective inhibitor of eIF2α dephosphorylation protects cells from ER stress. Science 307:935–939.
  • Bruhat, A., et al. 2000. Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter. Mol. Cell. Biol. 19:7192–7204.
  • Chen, C., E. E. Dudenhausen, Y. X. Pan, C. Zhong, and M. S. Kilberg. 2004. Human CCAAT/enhancer-binding protein β gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J. Biol. Chem. 279:27948–27956.
  • Cheng, G. Z., et al. 2008. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr. Cancer Drug Targets 8:2–6.
  • Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569–579.
  • Ehninger, D., P. J. de Vries, and A. J. Silva. 2009. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J. Intellect. Disabil. Res. 53:838–851.
  • Fernandez, J., I. Yaman, P. Sarnow, M. D. Snider, and M. Glou. 2002. Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2α. J. Biol. Chem. 277:19198–19205.
  • Fingar, D. C., and J. Blenis. 2004. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151–3171.
  • Fu, Y., et al. 2008. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc. Natl. Acad. Sci. U. S. A. 105:19444–19449.
  • Fujio, Y., et al. 1999. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell. Biol. 19:5073–5082.
  • Harama, D., et al. 2009. A sub-cytotoxic dose of subtilase cytotoxin prevents LPS-induced inflammatory responses, depending on its capacity to induce the unfolded protein response. J. Immunol. 183:1368–1374.
  • Hayakawa, K., et al. 2009. Acquisition of anergy to proinflammatory cytokines in nonimmune cells through endoplasmic reticulum stress response: a mechanism for subsidence of inflammation. J. Immunol. 182:1182–1191.
  • Hazeki, K., K. Nigorikawa, and O. Hazeki. 2007. Role of phosphoinositide 3-kinase in innate immunity. Biol. Pharm. Bull. 30:1617–1623.
  • Hiramatsu, N., A. Kasai, K. Hayakawa, J. Yao, and M. Kitamura. 2006. Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia. Nucleic Acids Res. 34(13):e13.
  • Hosoi, T., K. Hyoda, Y. Okuma, Y. Nomura, and K. Ozawa. 2007. Akt up- and down-regulation in response to endoplasmic reticulum stress. Brain Res. 1152:27–31.
  • Hu, P., Z. Han, A. D. Couvillon, R. J. Kaufman, and J. H. Exton. 2006. Autocrine tumor necrosis factor α links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 26:3071–3084.
  • Iwawaki, T., and R. Akai. 2006. Analysis of the XBP1 splicing mechanism using endoplasmic reticulum stress-indicators. Biochem. Biophys. Res. Commun. 350:709–715.
  • Iwawaki, T., R. Akai, K. Kohno, and M. Miura. 2004. A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat. Med. 10:98–102.
  • Katayama, T., et al. 2001. Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations. J. Biol. Chem. 276:43446–43454.
  • Kitamura, M. 1997. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-β1. J. Immunol. 159:1404–1411.
  • Kitamura, M., et al. 1994. Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J. Clin. Invest. 94:497–505.
  • Kodama, K., et al. 2005. Bidirectional regulation of monocyte chemoattractant protein-1 gene at distinct sites of its promoter by nitric oxide in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 289:C582–C590.
  • Lee, A. H., N. N. Iwakoshi, K. C. Anderson, and L. H. Glimcher. 2003. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc. Natl. Acad. Sci. U. S. A. 100:9946–9951.
  • Lee, A. H., N. N. Iwakoshi, and L. H. Glimcher. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23:7448–7459.
  • Leonardi, A., H. Ellinger-Ziegelbauer, G. Franzoso, K. Brown, and U. Siebenlist. 2000. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2. J. Biol. Chem. 275:271–278.
  • Li, Y., et al. 2008. Differential control of the CCAAT/enhancer-binding protein β (C/EBPβ) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. J. Biol. Chem. 283:22443–22456.
  • Lin, W. C., et al. 2002. Transcriptional activation of C/EBPβ gene by c-Jun and ATF2. DNA Cell Biol. 21:551–560.
  • Liu, F. Y., et al. 2010. Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br. J. Oral Maxillofac. Surg. 48:291–296.
  • Luo, S., C. Mao, B. Lee, and A. S. Lee. 2006. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol. Cell. Biol. 26:5688–5697.
  • Matthews, J. A., J. L. Belof, M. Acevedo-Duncan, and R. L. Potter. 2007. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells. Mol. Cell. Biochem. 298:109–123.
  • Misra, U. K., R. Deedwania, and S. V. Pizzo. 2006. Activation and cross-talk between Akt, NF-κB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J. Biol. Chem. 281:13694–13707.
  • Okada, T., et al. 2003. A serine protease inhibitor prevents endoplasmic reticulum stress-induced cleavage but not transport of the membrane-bound transcription factor ATF6. J. Biol. Chem. 278:31024–31032.
  • Okamura, M., et al. 2008. Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response. Am. J. Physiol. Renal Physiol. 295:F1495–F1503.
  • Ozawa, K., et al. 1999. 150-kDa oxygen-regulated protein suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 274:6397–6404.
  • Ozes, O. N., et al. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82–85.
  • Park, S., et al. 2009. RIP1 activates PI3K-Akt via a dual mechanism involving NF-κB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res. 69:4107–4111.
  • Patel, D. N., et al. 2007. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ activation. J. Biol. Chem. 282:27229–27238.
  • Paton, A. W., et al. 2006. AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443:548–552.
  • Paton, A. W., P. Srimanote, U. M. Talbot, H. Wang, and J. C. Paton. 2004. A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200:35–46.
  • Prösch, S., A. K. Heine, H. D. Volk, and D. H. Krüger. 2001. CCAAT/enhancer-binding proteins α and β negatively influence the capacity of tumor necrosis factor α to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by NF-κB during monocyte differentiation. J. Biol. Chem. 276:40712–40720.
  • Qiao, L., et al. 2003. Bile acid regulation of C/EBPβ, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol. Cell. Biol. 23:3052–3066.
  • Ramji, D. P., and P. Foka. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365:561–575.
  • Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. U. S. A. 85:3738–3742.
  • Rutkowski, D. T., and R. J. Kaufman. 2004. A trip to the ER: coping with stress. Trends Cell Biol. 14:20–28.
  • Schewe, D. M., and J. A. Aguirre-Ghiso. 2008. ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 105:10519–10524.
  • Shao, J., L. Qiao, R. C. Janssen, M. Pagliassotti, and J. E. Friedman. 2005. Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes 54:976–984.
  • Stein, B., P. C. Cogswell, and A. S. Baldwin, Jr. 1993. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:3964–3974.
  • Tremblay, F., and A. Marette. 2001. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J. Biol. Chem. 276:38052–38060.
  • Wolfson, J. J., et al. 2008. Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways. Cell. Microbiol. 10:1775–1786.
  • Yamagata, K., et al. 1994. Rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 269:16333–16369.
  • Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135–142.
  • Yamauchi, K., et al. 2006. Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes. Kidney Int. 70:892–900.
  • Yamazaki, H., et al. 2009. Activation of the Akt-NF-κB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J. Immunol. 183:1480–1487.
  • Yee, W. M., and P. F. Worley. 1997. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol. Cell. Biol. 17:921–933.
  • Yokouchi, M., et al. 2008. Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J. Biol. Chem. 283:4252–4260.
  • Yoshida, H., et al. 2000. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell. Biol. 20:6755–6767.
  • Zhang, K., and R. J. Kaufman. 2008. From endoplasmic-reticulum stress to the inflammatory response. Nature 454:455–462.
  • Zwergal, A., et al. 2006. C/EBPβ blocks p65 phosphorylation and thereby NF-κB-mediated transcription in TNF-tolerant cells. J. Immunol. 177:665–672.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.